The inclusion of PAX2 gene in targeted next-generation sequencing (NGS) gene panels for kidney diseases allows for the identification of disease-causing variants, even in cases where clinical diagnosis may not be accurate [8,9]. The gene discussed is PAX2; the disease is kidney disorder.